Persistence of Klebsiella pneumoniae ST258 as the predominant clone of carbapenemase-producing Enterobacteriaceae in post-acute-care hospitals in Israel, 2008-13

• Published in: Journal of antimicrobial chemotherapy Vol. 70; no. 1; pp. 89 - 92
• Main Authors: Adler, Amos, Hussein, Omar, Ben-David, Debby, Masarwa, Samira, Navon-Venezia, Shiri, Schwaber, Mitchell J, Carmeli, Yehuda
• Format: Journal Article
• Language: English
• Published: England Oxford Publishing Limited (England) 01.01.2015
• Subjects: Bacteria; Bacterial Proteins - secretion; beta-Lactamases - secretion; Cloning; Cross Infection - epidemiology; Cross Infection - microbiology; Cross-Sectional Studies; Enterobacteriaceae Infections - epidemiology; Enterobacteriaceae Infections - microbiology; Genotype; Hospitals; Humans; Israel; Klebsiella pneumoniae - classification; Klebsiella pneumoniae - enzymology; Klebsiella pneumoniae - isolation & purification; Molecular Epidemiology; Molecular Typing; Polymerase chain reaction; Prevalence; Retrospective Studies; Surveillance; Israel; clonal structure; colonization; KPC
• ISSN: 0305-7453; 1460-2091
• DOI: 10.1093/jac/dku333

To study the molecular characteristics of carbapenemase-producing Enterobacteriaceae (CPE) in post-acute-care hospitals (PACHs) in Israel and to analyse the temporal changes between 2008 and 2013. CPE isolates were obtained during two cross-sectional, point prevalence national surveys of PACHs in Israel performed in 2008 and 2013. Surveillance cultures were collected by streaking rectal swabs onto selective media. Isolates were identified to species level and tested for blaKPC, blaNDM and blaOXA-48 by PCR and by the Carba NP test. Molecular typing was done by PCR for the pilv-l gene, designed for the ST258 KPC-producing Klebsiella pneumoniae (KPC-KP) clone, BOX-PCR and MLST. The prevalence of CPE carriage in the first survey was 184/1147 (16%); all of the isolates were KPC-KP. The prevalence of CPE carriage in the second survey was 127/1287 (9.9%); of these isolates, 113 (89%) were KPC-KP, 9 (7%) were other KPC-producing species and 5 (4%) were NDM- and OXA-48-producing CPE (n = 1 and 4, respectively). The proportion of the KPC-KP population represented by the ST258 clone increased from 120/184 (65%) in 2008 to 91/113 (80%) in 2013. In 58% (71/122) of the KPC-CPE carriers identified in the 2013 survey, the source of acquisition was determined to be the PACH itself. All four OXA-48 CPE were acquired either directly or indirectly from patients arriving from the Palestinian Authority or Syria. Despite the decreased prevalence of CPE in Israeli PACHs, and the emergence of new types of CPE, the KPC-KP ST258 clone remains the predominant clone represented.